Core Laboratories Stock

Core Laboratories EBIT 2024

Core Laboratories EBIT

67.31 M USD

Ticker

CLB

ISIN

NL0000200384

WKN

897269

In 2024, Core Laboratories's EBIT was 67.31 M USD, a 17.34% increase from the 57.36 M USD EBIT recorded in the previous year.

The Core Laboratories EBIT history

YEAREBIT (undefined USD)
2029e-
2028e103.02
2027e91.41
2026e86.78
2025e111.32
2024e67.31
202357.36
202244
202143.7
202059.7
201996.7
2018120.7
2017111.8
201688.7
2015188.1
2014349.5
2013335.9
2012297.2
2011252.3
2010227.2
2009186.3
2008210.5
2007171.5
2006120.3
200560.9
200446.5

Core Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Core Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Core Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Core Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Core Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Core Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Core Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Core Laboratories’s growth potential.

Core Laboratories Revenue, EBIT and net profit per share

DateCore Laboratories RevenueCore Laboratories EBITCore Laboratories Net Income
2029e639.33 M undefined0 undefined76.74 M undefined
2028e623.17 M undefined103.02 M undefined70.82 M undefined
2027e604.49 M undefined91.41 M undefined62.05 M undefined
2026e611.56 M undefined86.78 M undefined75.55 M undefined
2025e586.5 M undefined111.32 M undefined76.67 M undefined
2024e537.03 M undefined67.31 M undefined41.68 M undefined
2023509.79 M undefined57.36 M undefined36.68 M undefined
2022489.7 M undefined44 M undefined19.5 M undefined
2021470.3 M undefined43.7 M undefined19.7 M undefined
2020487.3 M undefined59.7 M undefined-97.6 M undefined
2019668.2 M undefined96.7 M undefined102 M undefined
2018700.8 M undefined120.7 M undefined79.5 M undefined
2017647.8 M undefined111.8 M undefined83.1 M undefined
2016590.2 M undefined88.7 M undefined63.9 M undefined
2015797.5 M undefined188.1 M undefined114.8 M undefined
20141.09 B undefined349.5 M undefined257.5 M undefined
20131.07 B undefined335.9 M undefined242.8 M undefined
2012981.1 M undefined297.2 M undefined216.1 M undefined
2011907.6 M undefined252.3 M undefined184.7 M undefined
2010794.7 M undefined227.2 M undefined144.9 M undefined
2009695.5 M undefined186.3 M undefined113.6 M undefined
2008780.8 M undefined210.5 M undefined131.2 M undefined
2007670.5 M undefined171.5 M undefined121.1 M undefined
2006575.7 M undefined120.3 M undefined82.7 M undefined
2005483.5 M undefined60.9 M undefined31.2 M undefined
2004427.4 M undefined46.5 M undefined12.3 M undefined

Core Laboratories stock margins

The Core Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Core Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Core Laboratories.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Core Laboratories's sales revenue. A higher gross margin percentage indicates that the Core Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Core Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Core Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Core Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Core Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Core Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Core Laboratories Margin History

Core Laboratories Gross marginCore Laboratories Profit marginCore Laboratories EBIT marginCore Laboratories Profit margin
2029e21.54 %0 %12 %
2028e21.54 %16.53 %11.36 %
2027e21.54 %15.12 %10.27 %
2026e21.54 %14.19 %12.35 %
2025e21.54 %18.98 %13.07 %
2024e21.54 %12.53 %7.76 %
202321.54 %11.25 %7.19 %
202219.62 %8.99 %3.98 %
202121.77 %9.29 %4.19 %
202023.09 %12.25 %-20.03 %
201925.83 %14.47 %15.26 %
201829.1 %17.22 %11.34 %
201728.23 %17.26 %12.83 %
201625.87 %15.03 %10.83 %
201533.22 %23.59 %14.39 %
201438.7 %32.21 %23.73 %
201338.24 %31.29 %22.62 %
201236.62 %30.29 %22.03 %
201134.63 %27.8 %20.35 %
201035.35 %28.59 %18.23 %
200934.19 %26.79 %16.33 %
200834.08 %26.96 %16.8 %
200733.01 %25.58 %18.06 %
200629.29 %20.9 %14.37 %
200523.85 %12.6 %6.45 %
200421.29 %10.88 %2.88 %

Core Laboratories Aktienanalyse

What does Core Laboratories do?

Core Laboratories NV was originally founded in 1936 and is headquartered in Amsterdam, Netherlands. The company is a technology and service firm for the oil and gas industry, providing solutions for the extraction, processing, and marketing of oil and gas worldwide. The business model of Core Laboratories NV is focused on developing, validating, and selling technologies and services in the oil and gas industry. The company specializes in various areas: reservoir optimization and management, analysis and laboratory services, and research, development, and project solutions. The reservoir optimization and management division focuses on developing and implementing technologies and solutions that create optimal conditions for oil and gas extraction. Existing resources are examined to forecast the potential of each reservoir. The company offers various technologies, including CoreVault, a system for secure sample storage, and reservoir management software to achieve optimal conditions for extracting existing oil and gas reserves. The analysis and laboratory services division offers a comprehensive range of geological, chemical, and physical analyses necessary for identifying and quantifying oil and gas resources. This includes gas analysis, core analysis, in-situ analysis, and spectral analysis. The third division of Core Laboratories NV is research, development, and project performance. The company offers customized solutions to meet the specific requirements of its clients, including projects in exploration and field management. An example is the Oil Field Chemistry Program, which focuses on optimizing chemical use in relation to oil-water separation. Throughout its more than 80-year history, Core Laboratories NV has developed and commercialized many significant technologies, including non-destructive core analysis technologies and the CoreVacuum system, which removes water from a sample without drying out the rock. Core Laboratories NV also has several academic partnerships and research collaborations with leading institutions such as the University of Texas in Austin, the University of Alberta in Canada, and the University of Stavanger in Norway. Overall, Core Laboratories NV is an important partner in the oil and gas industry. With its innovative technologies and comprehensive knowledge and experience in the industry, the company offers customized solutions and services to meet its clients' requirements. Core Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Core Laboratories's EBIT

Core Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Core Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Core Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Core Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Core Laboratories stock

How much did Core Laboratories achieve in EBIT for the current year?

In the current year, Core Laboratories has achieved an EBIT of 67.31 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Core Laboratories.

How has the EBIT of Core Laboratories developed in recent years?

The EBIT of Core Laboratories has increased by 17.338% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Core Laboratories?

The EBIT of Core Laboratories is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Core Laboratories pay?

Over the past 12 months, Core Laboratories paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.23 %. For the coming 12 months, Core Laboratories is expected to pay a dividend of 0.04 USD.

What is the dividend yield of Core Laboratories?

The current dividend yield of Core Laboratories is 0.23 %.

When does Core Laboratories pay dividends?

Core Laboratories pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Core Laboratories?

Core Laboratories paid dividends every year for the past 22 years.

What is the dividend of Core Laboratories?

For the upcoming 12 months, dividends amounting to 0.04 USD are expected. This corresponds to a dividend yield of 0.24 %.

In which sector is Core Laboratories located?

Core Laboratories is assigned to the 'Energy' sector.

Wann musste ich die Aktien von Core Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Core Laboratories from 8/26/2024 amounting to 0.01 USD, you needed to have the stock in your portfolio before the ex-date on 8/5/2024.

When did Core Laboratories pay the last dividend?

The last dividend was paid out on 8/26/2024.

What was the dividend of Core Laboratories in the year 2023?

In the year 2023, Core Laboratories distributed 0.04 USD as dividends.

In which currency does Core Laboratories pay out the dividend?

The dividends of Core Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Core Laboratories stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Core Laboratories

Our stock analysis for Core Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Core Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.